CVS HEALTH CORPORATION Write off of Deferred Debt Issuance Cost
CVS HEALTH CORPORATION (CVS) reported Write off of Deferred Debt Issuance Cost of $8.00 million for the 1-month period ending 2021-12-31, per its 10-K filed 2024-02-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:WriteOffOfDeferredDebtIssuanceCost · last filed 2024-02-07
- CVS HEALTH CORPORATION write off of deferred debt issuance cost for the quarter ending 2016-09-30 was $4.00M.
| Period end | Write off of Deferred Debt Issuance Cost | Write off of Deferred Debt Issuance Cost 1 month | Write off of Deferred Debt Issuance Cost 3 month |
|---|---|---|---|
| 2021-12-31 | $8.00M 10-K · filed 2024-02-07 | ||
| 2021-08-31 | $26.00M 10-K · filed 2024-02-07 | ||
| 2020-12-31 | $45.00M 8-K · filed 2023-05-25 | ||
| 2020-08-31 | $47.00M 8-K · filed 2023-05-25 | ||
| 2019-08-31 | $5.00M 10-K · filed 2021-02-16 | ||
| 2016-09-30 | $4.00M 10-Q · filed 2016-11-08 | ||
| 2016-07-27 | $4.00M 8-K · filed 2019-08-08 | ||
| 2016-05-31 | $50.00M 8-K · filed 2019-08-08 | ||
| 2016-05-16 | $50.00M 10-Q · filed 2016-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |